Centre for Rehabilitation and Human Performance Research and Physiotherapy Directorate, Frederick Road Campus, University of Salford, Salford M6 6PU, UK.
Clin Rehabil. 2009 Nov;23(11):1018-33. doi: 10.1177/0269215509339004. Epub 2009 Sep 28.
To identify psychometrically robust and clinically feasible measures of walking and mobility in people with neurological conditions.
MEDLINE, CINAHL, EMBASE, PEDro and AMED.
Independent reviewers selected and extracted data from articles that assessed the reliability, validity, sensitivity to change or clinical utility of measures of walking and mobility in adult neurological conditions. Measures with 'good' psychometrics and 9/10 clinical utility scores were recommended.
Seventeen measures were selected. Of these, the 5-m and 10-m walk tests, six-minute walk test, High Level Mobility Assessment Tool (HiMAT) and the Rivermead Mobility Index (RMI) reached the required standards and are usable in clinical practice. None of the recommended measures assessed wheelchair mobility. The least frequently assessed property was sensitivity to change. Further measures could be recommended if the minimal detectable change were demonstrated.
The 5-m, 10-m and six-minute walk test, High Level Mobility Assessment Tool and the Rivermead Mobility Index are psychometrically robust measures of walking and mobility and are feasible for use in clinical practice.
确定在神经疾病患者中具有良好心理测量学特性和临床可行性的步行和移动能力测量方法。
MEDLINE、CINAHL、EMBASE、PEDro 和 AMED。
独立评审员从评估成人神经疾病患者步行和移动能力测量方法的可靠性、有效性、对变化的敏感性或临床实用性的文章中选择和提取数据。具有“良好”心理测量学特性和 9/10 临床实用性评分的测量方法被推荐使用。
共选择了 17 项措施。其中，5 米和 10 米步行测试、6 分钟步行测试、高级移动能力评估工具（HiMAT）和 Rivermead 移动能力指数（RMI）达到了所需的标准，可在临床实践中使用。没有推荐的措施评估轮椅移动能力。评估最少的属性是对变化的敏感性。如果证明了最小可检测变化，则可以推荐进一步的措施。
5 米、10 米和 6 分钟步行测试、高级移动能力评估工具和 Rivermead 移动能力指数是步行和移动能力的可靠心理测量学测量方法，并且在临床实践中具有可行性。
